Invention Application
US20120258071A1 Compositions and Methods of Use for MGD-CSF in Disease Treatment 有权
MGD-CSF在疾病治疗中的组成和使用方法

Compositions and Methods of Use for MGD-CSF in Disease Treatment
Abstract:
Disclosed is a newly identified secreted molecule, identified herein as “monocyte, granulocyte, and dendritic cell colony stimulating factor” (MGD-CSF), the polypeptide sequence, and polynucleotides encoding the polypeptide sequence. Also provided is a procedure for producing the polypeptide by recombinant techniques employing, for example, vectors and host cells. Additionally, procedures are described to modify the disclosed novel molecules of the invention to prepare fusion molecules. Also disclosed are methods for using the polypeptides and active fragments thereof for treatment of a variety of diseases, including, for example, cancer, autoimmune and inflammatory diseases, infectious diseases, and recurrent pregnancy loss.
Public/Granted literature
Information query
Patent Agency Ranking
0/0